147 related articles for article (PubMed ID: 8630511)
21. [Progress in the study of von Hippel-Lindau syndrome].
Chen F; Wu M
Zhonghua Yi Xue Za Zhi; 1997 Mar; 77(3):236-8. PubMed ID: 9596966
[No Abstract] [Full Text] [Related]
22. The Elongin BC complex and the von Hippel-Lindau tumor suppressor protein.
Conaway JW; Kamura T; Conaway RC
Biochim Biophys Acta; 1998 Apr; 1377(2):M49-54. PubMed ID: 9606976
[No Abstract] [Full Text] [Related]
23. The hereditary forms of pancreatic neuroendocrine tumors.
DeLellis RA
Adv Anat Pathol; 1999 May; 6(3):149-53. PubMed ID: 10342012
[TBL] [Abstract][Full Text] [Related]
24. Molecular cloning of the von Hippel-Lindau tumor suppressor gene and its role in renal carcinoma.
Gnarra JR; Duan DR; Weng Y; Humphrey JS; Chen DY; Lee S; Pause A; Dudley CF; Latif F; Kuzmin I; Schmidt L; Duh FM; Stackhouse T; Chen F; Kishida T; Wei MH; Lerman MI; Zbar B; Klausner RD; Linehan WM
Biochim Biophys Acta; 1996 Mar; 1242(3):201-10. PubMed ID: 8603073
[No Abstract] [Full Text] [Related]
25. A PCR generated BsaJ I RFLP in the promoter of the von Hippel-Lindau disease (VHL) tumour suppressor gene.
Geil L; Semenova E; Lerman MI; Kuzmin I
Mol Cell Probes; 1998 Oct; 12(5):343-4. PubMed ID: 9778462
[No Abstract] [Full Text] [Related]
26. VHL gene inactivation in an endolymphatic sac tumor associated with von Hippel-Lindau disease.
Kawahara N; Kume H; Ueki K; Mishima K; Sasaki T; Kirino T
Neurology; 1999 Jul; 53(1):208-10. PubMed ID: 10408561
[TBL] [Abstract][Full Text] [Related]
27. The von Hippel-Lindau tumor suppressor gene.
Kondo K; Kaelin WG
Exp Cell Res; 2001 Mar; 264(1):117-25. PubMed ID: 11237528
[TBL] [Abstract][Full Text] [Related]
28. Identification of elongin C sequences required for interaction with the von Hippel-Lindau tumor suppressor protein.
Takagi Y; Pause A; Conaway RC; Conaway JW
J Biol Chem; 1997 Oct; 272(43):27444-9. PubMed ID: 9341197
[TBL] [Abstract][Full Text] [Related]
29. Elongin BC complex prevents degradation of von Hippel-Lindau tumor suppressor gene products.
Schoenfeld AR; Davidowitz EJ; Burk RD
Proc Natl Acad Sci U S A; 2000 Jul; 97(15):8507-12. PubMed ID: 10900011
[TBL] [Abstract][Full Text] [Related]
30. The role of von Hippel-Lindau tumor suppressor protein and hypoxia in renal clear cell carcinoma.
Sufan RI; Jewett MA; Ohh M
Am J Physiol Renal Physiol; 2004 Jul; 287(1):F1-6. PubMed ID: 15180922
[TBL] [Abstract][Full Text] [Related]
31. Germline and somatic mutations in von Hippel-Lindau disease gene and its significance in the development of kidney cancer.
Shuin T; Kondo K; Ashida S; Okuda H; Yoshida M; Kanno H; Yao M
Contrib Nephrol; 1999; 128():1-10. PubMed ID: 10597373
[No Abstract] [Full Text] [Related]
32. Regulation of vascular endothelial growth factor by hypoxia and its modulation by the von Hippel-Lindau tumor suppressor gene.
Levy AP; Levy NS; Iliopoulos O; Jiang C; Kaplin WG; Goldberg MA
Kidney Int; 1997 Feb; 51(2):575-8. PubMed ID: 9027742
[TBL] [Abstract][Full Text] [Related]
33. von Hippel-Lindau protein mutants linked to type 2C VHL disease preserve the ability to downregulate HIF.
Hoffman MA; Ohh M; Yang H; Klco JM; Ivan M; Kaelin WG
Hum Mol Genet; 2001 May; 10(10):1019-27. PubMed ID: 11331612
[TBL] [Abstract][Full Text] [Related]
34. Von Hippel-Lindau disease: the role of gene analysis in affected families.
Riegler P; Huber W; Corradini R; Neumann HP; Glaesker S; Sessa A
Nephron; 2000 Jan; 84(1):95-7. PubMed ID: 10644921
[No Abstract] [Full Text] [Related]
35. New insights into an enigmatic tumour suppressor.
Ratcliffe PJ
Nat Cell Biol; 2003 Jan; 5(1):7-8. PubMed ID: 12511881
[No Abstract] [Full Text] [Related]
36. Von Hippel-Lindau disease and sporadic renal cell carcinoma.
Zbar B
Cancer Surv; 1995; 25():219-32. PubMed ID: 8718521
[TBL] [Abstract][Full Text] [Related]
37. Endolymphatic sac tumors in patients with and without von Hippel-Lindau disease: the role of genetic mutation, von Hippel-Lindau protein, and hypoxia inducible factor-1alpha expression.
Jensen RL; Gillespie D; House P; Layfield L; Shelton C
J Neurosurg; 2004 Mar; 100(3):488-97. PubMed ID: 15035285
[TBL] [Abstract][Full Text] [Related]
38. Molecular pathogenesis of the von Hippel-Lindau hereditary cancer syndrome: implications for oxygen sensing.
Yang H; Kaelin WG
Cell Growth Differ; 2001 Sep; 12(9):447-55. PubMed ID: 11571227
[No Abstract] [Full Text] [Related]
39. Molecular basis of the VHL hereditary cancer syndrome.
Kaelin WG
Nat Rev Cancer; 2002 Sep; 2(9):673-82. PubMed ID: 12209156
[TBL] [Abstract][Full Text] [Related]
40. Identification of a novel mutation (c279delC) and a polymorphism (c291C>G) in the von Hippel-Lindau gene in Italian patients.
Moore PS; Antonello D; Martignoni G; Racchini C; Ventrucci M; Scarpa A
Hum Mutat; 2000 Jun; 15(6):582. PubMed ID: 10862095
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
